Medical Innovation Exchange

Novartis halts phase 1 cancer trial of CD73 antagonist over efficacy, but combo studies continue

https://www.fiercebiotech.com/biotech/novartis-halts-phase-1-cd73-antagonist-over-efficacy-combo-trials-continue

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!